Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...
Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results